United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Antoxerene and Juvenescence launch FoxBio to develop anti-aging drugs Antoxerene, a pharmaceutical company dedicated to developing senolytic drugs, has partnered with investment firm Juvenescence to form a… bypharmanewsdailyJuly 15, 2018
